You are here: Industry Insights > Protein

News List

AHA News: Potentially Fatal Buildup of Proteins in the Heart Often Goes Undiagnosed drugs
May 22, 2019
AHA News: Potentially Fatal Buildup of Proteins in the Heart Often Goes Undiagnosed.
Creating a modern landscape europeanpharmaceuticalreview
May 17, 2019
There are many business challenges to developing a biologics drug, one of which is effective data management.
Researchers block protein that plays a key role in Alzheimer's disease worldpharmanews
May 16, 2019
Researchers block protein that plays a key role in Alzheimer's disease.
Researchers block protein that plays a key role in Alzheimer's disease worldpharmanews
May 16, 2019
Researchers block protein that plays a key role in Alzheimer's disease.
New drug for Huntington lowers levels of disease-causing protein europeanpharmaceuticalreview
May 10, 2019
A new drug for Huntington disease is found to be safe and lowers levels of the abnormal protein that causes the debilitating disease in patients.
Niclosamide could lead the fight against Parkinson’s disease europeanpharmaceuticalreview
May 05, 2019
Drug molecule in tapeworm medicine activates protein implicated in the development of Parkinson’s disease…
SomaLogic & Janssen Enter Agreement contractpharma
April 15, 2019
SomaLogic to analyze ~5000 proteins in each of at least 15,000 clinical samples from Janssen to identify & validate protein biomarkers for use to treat diseases...
Protein content as a marker for response to therapy in brain cancer worldpharmanews
March 06, 2019
Brain tumors vary widely in how they respond to treatment. However, early assessment of therapy response is essential in order to choose the best possible treatment for the patient.
Direct infusion of GDNF into brain offers hope for Parkinson’s pharmaceutical-technology
February 28, 2019
An experimental study funded by Parkinson’s UK has demonstrated promising results for infusion of a naturally-occurring protein called GDNF directly into the brain...
Novartis to divest Proleukin’s US rights to Clinigen for $210m pharmaceutical-technology
February 14, 2019
Novartis has signed an agreement to divest the US rights to its Proleukin (aldesleukin) medicine to UK-based Clinigen Group for a total cash consideration of up to $210m.....

Previous page 1 2 3 4 5 6 7 8 9 Next page